Amaran specializes in curating and selling decorative arts, personal accessories, furniture, and fine jewelry, featuring unique and original designs from various artists.

Amaran

Amaran Biotechnology, Inc. | 588 followers on LinkedIn. Formulating the Future, Producing Success | Amaran Biotechnology, Inc. is a contract development and manufacturing company established to provide solutions in drug process development, analytical services and cGMP manufacturing of high-value biopharmaceuticals. Amaran Biotech cultivates quality and integrity values into the employee culture to provide excellence in manufacturing safe and high quality pharmaceuticals which adhere to global regulatory requirements.

Dr.

Director of Business Technology & PMO

William Feng, MSc. MBA. PMP

Biotech/Pharmaceutical Professional

Yu-Hung Chiu

PR & Marketing Manager at Amaran Biotechnology, Inc.

Doreen Lin

Quality Assurance Manager at Amaran

Matthew Liu

Amaran Biotechnology, Inc.

#AmaranBiotech is a CDMO to provide quality solutions in drug process development, analytical services and cGMP manufacturing of high-value biopharmaceuticals. #AmaranBiotech aspires to set the gold standard in Taiwan for excellence in manufacturing safe and high quality pharmaceuticals which adhere to global pharmaceutical regulatory requirements. 💡 Know more our CDMO services: https://lnkd.in/gt8VUDTT

#AmaranBiotech is excited to welcome Christa Maurer , Sr. Director of QA at OBI Pharma , to share her valuable insights on FDA inspections and GXP practices. Her expertise will provide our team with a deeper understanding of regulatory expectations and best practices. #Qualityculture

🚀 Amaran Biotech X Cytiva: Advanced Aseptic Processing Technology Workshop We’re excited to announce that #AmaranBiotech and #CytivaTaiwan are co-hosting the "Advanced Aseptic Processing Technology for Protein and New Modalities Workshop"! 📅 Date: November 7th, 2024 📍 Venue: Hsinchu Biomedical Science Park & Amaran Biotech Facility Join us to explore cutting-edge aseptic filling technologies, including the SA25 Aseptic Filling Workcell, and the applications in protein and new modality manufacturing. 🔗 Register now: https://lnkd.in/gWniGWXa #AmaranBiotech #CytivaTaiwan #AsepticFilling #SA25

Bioconjugation is a chemical process that forms a covalent link between two molecules, at least one of which is a biomolecule. This technique has revolutionized various fields, including medicine, diagnostics, and biotechnology. Application of bioconjugation is pivotal in the development of biopharmaceuticals, including: 🔹 Antibody-Drug Conjugates (ADCs): These combine the targeting capability of antibodies with the potency of cytotoxic drugs, allowing for precise delivery to cancer cells. 🔹 Pegylated Proteins: Attaching polyethylene glycol (PEG) to proteins increases their stability and half-life. 🔹 siRNA Conjugates: Enhance the delivery and efficacy of small interfering RNA (siRNA) therapies. 🔹 Vaccine Conjugates: Improve the immune response by linking antigens to carrier proteins. Advantages of bioconjugation are: 💡 Targeted Delivery: Enhances the specificity of drug delivery, reducing side effects and improving therapeutic efficacy. 💡 Increased Stability: Conjugation can enhance the stability and half-life of therapeutic molecules. 💡 Versatility: Applicable to a wide range of biomolecules and small molecules, enabling diverse applications in diagnostics and therapeutics. #AmaranBiotech is at the forefront of bioconjugation technology. The company specializes in the development and manufacturing of high-value biopharmaceuticals. Our state-of-the-art facilities and expertise in bioconjugation enhance the ability to produce complex biopharmaceuticals, contributing to advancements in targeted therapies and personalized medicine.

Leading the way at BioJapan 2024, Shiing-Jer Twu, Chairman of the Development Center for Biotechnology (DCB), and Michael Huang , Director of BPIPO and Vice President of DCB, led a delegation of 12 innovative Taiwanese biotech companies. Held at the PACIFICO Yokohama International Conference Center, the event provided a global stage to showcase Taiwan’s biotech innovations with distinct companies. Through strategic industry visits and meetings, DCB and BPIPO facilitated in-depth exchanges with top Japanese biotech and pharmaceutical organizations. These efforts are driving bilateral partnerships and accelerating the global expansion of Taiwan's biotech industry. 🌍 Read more at 👉🏻 https://bit.ly/3NngFM8 LumiSTAR Biotechnology, Inc. 昱星生物科技 , 向榮生技UnicoCell Biomed , Amaran Biotechnology, Inc. , KriSan Biotech Co., Ltd. , King's Ground Biotech , FEBICO遠東生技 , ACRO Biomedical Co., Ltd. , Steminent Biotherapeutics , Level Biotechnology Inc #BioJapan2024 #Biotech #BPIPO #DCB #TaiwanBiotech #GlobalExpansion #Innovation #ShiingJerTwu #MichaelHuang

GeneOnline

<TBIO Activity> BioJapan 2024 #BioJapan2024 (by BioJapan / JTB Communication Design ) kicked off on Oct. 9 at the Pacifico Yokohama Convention Center for 3 days till the 11th, featuring over 200 forums, seminars and corporate presentations, with 460 companies exhibiting, and a total of 1,486 organizations participating in partnering. A record-breaking number of attendees was reached on the first day, and the organizer noted that this year's BioJapan has expanded by more than 20% compared to previous years. Under the organization and call of 生技中心 ( #DCB , Development Center for Biotechnology) and #BPIPO (Biotechnology and Pharmaceutical Industries Promotion Office, MOEA), the Taiwan Pavilion has nearly 60 industry, government, academic and research units participated in BioJapan 2024 exhibition and partnering, which surpassed the previous years. The Taiwan Pavilion Exhibitors: ACRO Biomedical Co., Ltd. / Amaran Biotechnology, Inc. / Bora Biologics CO., LTD. / Department of Industrial Technology, MOEA / Development Center for Biotechnology / FEBICO遠東生技 / King's Ground Biotech / KriSan Biotech Co., Ltd. / Level Biotechnology Inc. (3118) / LumiSTAR Biotechnology, Inc. 昱星生物科技 / 國家科學及技術委員會 / PELL Bio-Med Technology CO.,LTD. / Steminent Biotherapeutics / TaiGen Biotechnology LTD. / Taiwan Bio Industry Organization / 向榮生技UnicoCell Biomed The exhibition officially ended yesterday (10/11). The total number of visitors during the three-day exhibition was: 18,000+. Well done, Taiwan Delegation, and welcome home!

Taiwan Bio Industry Organization (Taiwan BIO)

🌟 #AmaranBiotech is currently at #BioJapan in Yokohama! If you're attending, we invite you to visit us at the Taiwan Pavilion (Booth No. B-56). Meet our representatives, Ryan C.W. Lo and MingJue Liu , who are excited to discuss our CDMO solutions and explore potential collaborations. We look forward to connecting with you! #BioJapan #AmaranBiotech #CDMO

Taiwan’s delegation is making a powerful impact at Shonan Health Innovation Park ’s site visit during Bio Japan 2024! Leading the charge are key figures like Shiing Jer Twu, Chairman of the Development Center for Biotechnology (DCB), along with representatives from BPIPO. 🔬 In addition, multiple Taiwanese companies also present are showcasing their innovations including LumiSTAR Biotechnology, Inc. 昱星生物科技 , OEP GROUP 友華集團 , 向榮生技UnicoCell Biomed , Amaran Biotechnology, Inc. , KriSan Biotech Co., Ltd. , King's Ground Biotech , Protect Animal Health Inc. , FEBICO遠東生技 , and ACRO Biomedical Co., Ltd. 🌏 Stay tuned for more exclusive content on Bio Japan 2024 with GeneOnline!💡 #BioJapan2024 #TaiwanBiotech #GlobalInnovation #BiotechLeaders #DCB #BPIPO #Networking #Partnerships

#AmaranBiotech is delighted to have visited Shonan iPark, one of Japan’s largest life science hubs, and to participate in its Global Showcase event as part of the BPIPO Taiwan delegation. It was a great opportunity to engage with 35 companies from across the globe—including the U.S., Korea, France, China, Switzerland, Sweden, and Ireland. We’re excited about the collaborations and opportunities that lie ahead! 🌍🤝✨ #ShonaniPark #BPIPO

<TBIO Activity> TBIO will join the upcoming #BioJapan2024 (by BioJapan / JTB Communication Design ) with Biotechnology and Pharmaceutical Industries Promotion Office ( #BPIPO ) and the following companies at the Taiwan Pavilion (➡️Booth No. B-56): Amaran Biotechnology, Inc. 向榮生技UnicoCell Biomed FEBICO遠東生技 #TaiGenBiotechnology ( 太景生物科技股份有限公司 ) LumiSTAR Biotechnology, Inc. 昱星生物科技 Bora Pharmaceuticals (Bora Biologics) King's Ground Biotech Level Biotechnology Inc. (3118) 生技中心 (Development Center for Biotechnology) PELL Bio-Med Technology (沛爾生醫) KriSan Biotech Co., Ltd. Steminent Biotherapeutics ACRO Biomedical Co., Ltd. Look up for more Taiwanese companies as Exhibitors and in Partnering: https://lnkd.in/g9wg647u .. Taiwan Pavilion Activities: 👉 Thursday Oct. 10 at 10:15-11:30 Main Stage Seminar - Biocluster Summit "Taiwan's Key Role in Building Successful Asian Biotech Ventures" by Dr. Michael Huang, Acting Director, BPIPO 👉 Thursday Oct. 10 at 16:00-17:00 HAPPY HOUR at the Taiwan Pavilion Please feel free to stop by at booth ⭐B-56⭐ to say hi, or schedule a partnering meeting with us!

Metric
Company Name	Amaran
Symbol
MSH ID	COM:AMARAN
Market	PRIVATE
Sector	Consumer Goods
Industry	Retail
Country	US
Stage
Employee Count
Website	amaran.com
LinkedIn	amaran-biotechnology-inc.
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AMAR

COM:AMARAN

Amaran

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue